Pfizer to seek emergency approval for vaccine
Follow The Hawk on Google News+ FollowAdvertisement

New York: Pfizer on Friday announced that it is moving ahead with its request of asking the US regulators to allow emergency use of its Covid-19 vaccine, which has shown 95 per cent efficacy in a totality of two data sets released in the last 10 days.
Unless some nasty surprises turn up, Pfizer's action on Friday could be the first step towards vaccinating the most vulnerable Americans by December end.
Advertisement
Pfizer and another US company, Moderna, have broken all vaccine development speed records in their race for a cure over the last nine months.
Also readFSSAI to initiate action against Bisleri over unsafe water sample
US regulators are standing by for the approval process while coronavirus cases are surging to record levels across all the 50 states.
The Vaccines and Related Biological Products Advisory Committee in the US Food and Drug Administration is a key player in how this process rolls along.
Advertisement
Pfizer's submission also includes safety data on approximately 100 children aged 12-15 years.
Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead
"Our work to deliver a safe and effective vaccine has never been more urgent," Pfizer CEO Albert Bourla said in a statement.
Pfizer and BioNTech expect to produce a total of 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021. US regulators hope to have 20 million vaccine doses each from Moderna and Pfizer available for distribution in late December.
--IANS
Get The Hawk first on Google
Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.
Advertisement








